Acer therapeutics reports q1 2023 financial results and provides corporate update

U.s. olpruva™ launch progressing ahead of schedule with drug-in-channel now anticipated in mid-june 2023 u.s. olpruva™ launch progressing ahead of schedule with drug-in-channel now anticipated in mid-june 2023
ACER Ratings Summary
ACER Quant Ranking